WHO ICTRP trial
COMPARATIVE, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-MASKED STUDY OF…
PER-023-03 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-023-03 |
|---|---|
| Public title | COMPARATIVE, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-MASKED STUDY OF AZITROMYCIN SR VERSUS LEVOFLOXACIN FOR THE TREATMENT OF PNEUMONIA ACQUIRED IN THE MILD TO MODERATE COMMUNITY IN ADULTS |
| Scientific title | COMPARATIVE, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-MASKED STUDY OF AZITROMYCIN SR VERSUS LEVOFLOXACIN FOR THE TREATMENT OF PNEUMONIA ACQUIRED IN THE MILD TO MODERATE COMMUNITY IN ADULTS |
| Primary sponsor | PFIZER S.A., |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | I |
| Countries | India;Germany;Spain;Finland;France;Italy;Argentina;Brazil;Chile;Costa Rica;Dominican Republic;Mexico;Panama;Peru;United States |
| Conditions | -J159 Bacterial pneumonia, unspecified Bacterial pneumonia, unspecified;J159;Bacterial pneumonia, unspecified |
| Interventions | Group name:Azithromycin 2 g Type of group;1 N° of participants:201 Intervention(s) description:Azithromycin SR 2.0 g orally will be administered once and then placebo of Levofloxacin 500 mg once a day for 7 days. Group name:Levofloxacin 500… |
| Registration date | May 18, 2003 |
| Target size | 0 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: